John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Okta
OKTA
$23.5B
| $35.7M | 0.08% |
340,832
+274,832
| +416% | +$25.4M |
|
277
Kimberly-Clark
KMB
$36.4B
| $35.5M | 0.08% |
274,727
-154,723
| -36% | -$19M |
|
278
FTAI Aviation
FTAI
$21.5B
| $35.5M | 0.08% |
527,109
-63,195
| -11% | -$3.47M |
|
279
iShares US Technology ETF
IYW
$24.9B
| $34.8M | 0.08% |
257,800
-183,200
| -42% | -$23.8M |
|
280
Corteva
CTVA
$54.6B
| $34.5M | 0.08% |
599,078
-1,080,034
| -64% | -$55.8M |
|
281
SBA Communications
SBAC
$19.4B
| $34.4M | 0.08% |
+158,626
| New | +$35.3M |
|
282
ArcelorMittal
MT
$54.4B
| $34.4M | 0.08% |
1,245,777
-873,990
| -41% | -$23.6M |
|
|
BECN
283
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $34.3M | 0.08% |
350,008
-139,983
| -29% | -$12.2M |
|
284
iShares MSCI Japan ETF
EWJ
$22.4B
| $34.3M | 0.08% |
480,800
+422,700
| +728% | +$28.7M |
|
285
Aecom
ACM
$8.34B
| $34.1M | 0.08% |
348,168
-75,310
| -18% | -$6.81M |
|
286
Axalta
AXTA
$7.75B
| $34M | 0.08% |
989,295
+903,595
| +1,054% | +$29.5M |
|
287
State Street SPDR S&P Metals & Mining ETF
XME
$4.63B
| $34M | 0.08% |
563,900
-400,300
| -42% | -$22.9M |
|
288
iShares S&P 100 ETF
OEF
$20.3B
| $33.8M | 0.08% |
136,600
-71,200
| -34% | -$16.8M |
|
289
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
| $33.4M | 0.08% |
665,150
+661,300
| +17,177% | +$32.6M |
|
290
Prologis
PLD
$135B
| $33.4M | 0.08% |
256,692
+29,874
| +13% | +$3.9M |
|
|
JWN
291
DELISTED
Nordstrom
JWN
| $33.2M | 0.08% |
1,635,766
-499,882
| -23% | -$9.46M |
|
292
Magnolia Oil & Gas
MGY
$6.67B
| $32.9M | 0.08% |
1,268,481
+585,577
| +86% | +$12.8M |
|
293
Frontline
FRO
$9.72B
| $32.6M | 0.08% |
1,393,080
-2,157,605
| -61% | -$48.7M |
|
294
United Therapeutics
UTHR
$22B
| $32.4M | 0.08% |
141,086
+51,507
| +57% | +$11.6M |
|
295
Parker-Hannifin
PH
$126B
| $32.4M | 0.08% |
58,277
+46,496
| +395% | +$23.6M |
|
296
STMicroelectronics
STM
$45.1B
| $32.2M | 0.08% |
745,464
-271,275
| -27% | -$12.2M |
|
297
Credo Technology Group
CRDO
$43B
| $32.2M | 0.08% |
1,518,333
+642,601
| +73% | +$13.5M |
|
|
MRUS
298
DELISTED
Merus
MRUS
| $32.1M | 0.08% |
712,109
+397,056
| +126% | +$16.1M |
|
299
Amgen
AMGN
$238B
| $32M | 0.08% |
112,383
+15,142
| +16% | +$4.43M |
|
300
Ascendis Pharma A/S
ASND
$16.6B
| $31.8M | 0.07% |
+210,325
| New | +$30M |
|
Similar funds
John Overdeck's Q1 2024 Portfolio in Review
As of Q1 2024, John Overdeck held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
John Overdeck withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, John Overdeck opened a new position in Pfizer worth $234M.
- John Overdeck's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- John Overdeck added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- John Overdeck's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- John Overdeck fully exited Rivian in Q1 2024, selling an estimated $158M.
- John Overdeck's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- John Overdeck opened 408 new positions and closed 532 in Q1 2024.
- John Overdeck's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.